ArticleBMC musculoskeletal disorders2026
Automatic diagnosis of osteonecrosis of the femoral head and segmentation of necrotic regions using deep learning at computed tomography: a real-world multicenter study.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundComputed tomography (CT) is essential for diagnosing osteonecrosis of the femoral head (ONFH) due to its superior visualization of osseous structures, yet CT-based deep learning (DL) models remain underexplored in real-world settings.
methodsThis retrospective multicenter study developed a two-stage DL model integrating Vision Transformer (ViT) and Swin Transformer (SwinT) for ONFH diagnosis and necrotic segmentation, using coronal CT images from 2,312 patients (53,828 images) across four hospitals from February 2023 to June 2024. The data from three hospitals were split 7:1:2 for training, validation, and internal testing, with the fourth serving as the external test set. Diagnostic performance was evaluated at both the slice and patient levels using the area under the receiver operating characteristic curve (AUC), sensitivity, and negative predictive value (NPV) while segmentation performance was assessed using the Dice coefficient and HD95. Human-computer comparison trials were conducted against three orthopaedic surgeons.
resultsAt the slice level, the model achieved robust performance with strong results in internal test set (AUC = 0.98, sensitivity = 98.91%, NPV = 98.66%, Dice = 72.64%, HD95 = 4.51 mm) and external test set (AUC = 0.97, sensitivity = 99.61%, NPV = 99.63%, Dice = 69.11%, HD95 = 5.27 mm). At the patient level, diagnostic performance remained high, with AUCs of 0.98 and 0.97 in the internal and external test sets, respectively. It outperformed surgeons in diagnosis and matched a 10-year-experienced attending in segmentation.
conclusionOur CT-based two-stage DL model exhibits high accuracy and strong generalizability for ONFH diagnosis and necrotic segmentation, providing a technically robust foundational framework with promising clinical translational potential for ONFH management.
trial registrationThis study was registered in the Chinese Clinical Trial Registry chictr.org.cn (Registration ID: ChiCTR2300067945, 01/02/2023).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.